Hilar Lymph Node Tuberculosis: Causes and Treatment
Hilar lymph node tuberculosis is a form of TB affecting the lymph nodes at the lung hilum. It occurs most frequently in children and requires prompt treatment.
Things worth knowing about "Hilar Lymph Node Tuberculosis"
Hilar lymph node tuberculosis is a form of TB affecting the lymph nodes at the lung hilum. It occurs most frequently in children and requires prompt treatment.
What is Hilar Lymph Node Tuberculosis?
Hilar lymph node tuberculosis is a specific form of tuberculosis (TB) in which infection with the bacterium Mycobacterium tuberculosis primarily affects the lymph nodes located at the lung hilum -- the central region where blood vessels, bronchi, and lymphatic vessels enter the lungs. These lymph nodes are part of the immune system and respond to infection with swelling and inflammation. This form is also referred to as primary tuberculosis and is most common in children and adolescents, although adults can also be affected.
Causes
Hilar lymph node tuberculosis is caused by infection with Mycobacterium tuberculosis, an acid-fast rod-shaped bacterium. Transmission occurs through:
- Droplet infection: Inhalation of airborne particles containing the bacterium, released by infected individuals when coughing, sneezing, or speaking.
- Close contact with a person suffering from active pulmonary tuberculosis.
Following the initial lung infection (primary infection), bacteria travel via the lymphatic system to the hilar lymph nodes, triggering a pronounced inflammatory response. The resulting primary complex consists of the lung focus and the affected hilar lymph nodes.
Symptoms
Symptoms can vary and are not always clearly defined. Common signs of hilar lymph node tuberculosis include:
- Persistent low-grade fever lasting several weeks
- Night sweats
- Unintentional weight loss and loss of appetite
- Chronic cough, sometimes with mucus production
- Fatigue and general malaise
- In children: failure to thrive
- In rare cases: breathing difficulties due to compression of the airways by significantly enlarged lymph nodes (mediastinal compression)
In many cases, especially in the early stages, the disease may be asymptomatic or present with only mild symptoms.
Diagnosis
Diagnosing hilar lymph node tuberculosis requires several investigative steps:
Imaging
- Chest X-ray: Reveals enlarged hilar lymph nodes (unilateral or bilateral hilar widening) and possible pulmonary infiltrates.
- Chest computed tomography (CT): Provides a more detailed assessment of lymph nodes and helps differentiate TB from other causes of hilar enlargement.
Microbiological and Immunological Tests
- Tuberculin skin test (Mantoux test): Assesses the immune response to tuberculin antigens.
- Interferon-gamma release assays (IGRA): Blood tests detecting sensitization to Mycobacterium tuberculosis (e.g., QuantiFERON-TB Gold).
- Sputum examination: Microscopy and culture for acid-fast bacilli; often difficult to perform in young children.
- Bronchoscopy with bronchoalveolar lavage (BAL): Collection of airway secretions for microbiological analysis.
- Lymph node biopsy: In unclear cases, tissue sampling for histological and microbiological confirmation may be required.
Additional Tests
- Blood count and inflammatory markers (ESR, CRP)
- PCR-based nucleic acid amplification tests for rapid pathogen detection
Treatment
Treatment of hilar lymph node tuberculosis follows international TB management standards and involves a combination of multiple antibiotics to prevent the development of drug resistance.
Standard Therapy (WHO Recommendation)
- Intensive phase (2 months): Four-drug regimen comprising Isoniazid (INH), Rifampicin (RMP), Pyrazinamide (PZA), and Ethambutol (EMB).
- Continuation phase (4 months): Ongoing treatment with Isoniazid and Rifampicin.
The total treatment duration is typically 6 months. In cases of complications or drug-resistant strains, treatment may be extended or modified.
Special Considerations in Children
In children, drug dosages are adjusted according to body weight. Pyridoxine (Vitamin B6) supplementation is often co-administered with Isoniazid therapy to prevent peripheral neuropathy. Regular monitoring of liver function tests is important throughout treatment.
Supportive Measures
- Adequate nutrition and vitamin supplementation
- Regular medical follow-up and therapy monitoring
- In severe cases with airway compression: corticosteroids as adjunctive anti-inflammatory therapy
Prognosis
With early diagnosis and consistent treatment, the prognosis for hilar lymph node tuberculosis is generally favorable. Most patients recover completely. Without treatment, however, the disease can progress and lead to serious complications such as miliary tuberculosis (hematogenous spread of bacteria) or tuberculous meningitis.
References
- World Health Organization (WHO): Tuberculosis. Global Tuberculosis Report 2023. Geneva: WHO, 2023.
- Marais BJ et al.: The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. International Journal of Tuberculosis and Lung Disease, 2004; 8(4): 392-402.
- Starke JR, Donald PR (eds.): Handbook of Child and Adolescent Tuberculosis. Oxford University Press, 2016.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryMacronutrients
Portion control
Food craving
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Hilar Lymph Node Tuberculosis-en